Comments on "Cost of decentralized CAR T cell production in an academic non-profit setting".

Schmitt, Michael; Schmitt, Anita; Thalheimer, Markus; Dreger, Peter; Müller-Tidow, Carsten

Schmitt, Michael; Schmitt, Anita; Thalheimer, Markus; Dreger, Peter; Müller-Tidow, Carsten.

Afiliação

Schmitt M; Department of Internal Medicine V, Hematology, Oncology, Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.
Schmitt A; Department of Internal Medicine V, Hematology, Oncology, Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.
Thalheimer M; Quality Management/Medical Controlling, University Hospital Heidelberg, Heidelberg, Germany.
Dreger P; Department of Internal Medicine V, Hematology, Oncology, Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.
Müller-Tidow C; Department of Internal Medicine V, Hematology, Oncology, Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.

Int J Cancer ; 148(2): 514-515, 2021 01 15.

Article em En | MEDLINE | ID: mdl-32798335

Assuntos

Receptores de Antígenos Quiméricos; Imunoterapia Adotiva; Linfócitos T

Palavras-chave

CAR T cells; Immunotherapy; cell therapy; costs; gene therapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores de Antígenos Quiméricos Tipo de estudo: Health_economic_evaluation Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google